FR2221179B1 - - Google Patents

Info

Publication number
FR2221179B1
FR2221179B1 FR7408677A FR7408677A FR2221179B1 FR 2221179 B1 FR2221179 B1 FR 2221179B1 FR 7408677 A FR7408677 A FR 7408677A FR 7408677 A FR7408677 A FR 7408677A FR 2221179 B1 FR2221179 B1 FR 2221179B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7408677A
Other versions
FR2221179A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Seika Kaisha Ltd
Original Assignee
Meiji Seika Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha Ltd filed Critical Meiji Seika Kaisha Ltd
Publication of FR2221179A1 publication Critical patent/FR2221179A1/fr
Application granted granted Critical
Publication of FR2221179B1 publication Critical patent/FR2221179B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C13—SUGAR INDUSTRY
    • C13B—PRODUCTION OF SUCROSE; APPARATUS SPECIALLY ADAPTED THEREFOR
    • C13B50/00—Sugar products, e.g. powdered, lump or liquid sugar; Working-up of sugar
    • C13B50/004—Agglomerated sugar products; Agglomeration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7408677A 1973-03-16 1974-03-14 Expired FR2221179B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3007373A JPS5418330B2 (fr) 1973-03-16 1973-03-16

Publications (2)

Publication Number Publication Date
FR2221179A1 FR2221179A1 (fr) 1974-10-11
FR2221179B1 true FR2221179B1 (fr) 1980-05-09

Family

ID=12293614

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7408677A Expired FR2221179B1 (fr) 1973-03-16 1974-03-14

Country Status (5)

Country Link
US (1) US3932615A (fr)
JP (1) JPS5418330B2 (fr)
DE (1) DE2412117A1 (fr)
FR (1) FR2221179B1 (fr)
GB (1) GB1458431A (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4076804A (en) * 1975-07-18 1978-02-28 Abbott Laboratories Erythromycin therapy
GB1561301A (en) * 1976-01-02 1980-02-20 Beecham Group Ltd Orally administrable pharmaceutical composition
CH635862A5 (de) * 1977-10-15 1983-04-29 Ciba Geigy Ag Verfahren zur granulierung von pigmenten.
EP0012496B1 (fr) * 1978-12-08 1983-07-20 Beecham Group Plc Procédé de préparation du sel de sodium de l'amoxycilline et solutions aqueuses correspondantes
US4195078A (en) * 1979-03-09 1980-03-25 Eli Lilly And Company Nabilone granulation
US4327080A (en) * 1981-07-13 1982-04-27 E. R. Squibb & Sons, Inc. Novel Bendroflumethiazide formulations and method
GB2124644B (en) * 1982-07-05 1986-03-19 Lion Corp Method for granulating cationic surfactant
GB2132890B (en) * 1983-01-06 1986-12-03 Andrew Macarthy Reynolds Oral veterinary drug
JPS59155309A (ja) * 1983-02-22 1984-09-04 Teijin Ltd 活性型ビタミンｄ↓３類組成物
GB8428952D0 (en) * 1984-11-16 1984-12-27 Beecham Group Plc Formulations
US4847078A (en) * 1987-01-14 1989-07-11 Arseco, Inc. Storage stable topical composition having moisture control agent
JP2525478B2 (ja) * 1989-03-01 1996-08-21 帝人株式会社 安定性の改良された活性型ビタミンｄ▲下３▼類固型製剤
US5549757A (en) * 1994-06-10 1996-08-27 Ingredient Technology Corporation Process for recrystallizing sugar and product thereof
GB9614759D0 (en) * 1996-07-13 1996-09-04 Agglomeration Technology Ltd Granulated sugar product
FR2769636B1 (fr) * 1997-10-13 2000-01-28 Saint Louis Sucre Sa Produit hydrophobe a base de saccharose
US6123980A (en) * 1997-12-01 2000-09-26 Imperial Sugar Company Preparing granulated sugar blends and products
DE60008497T2 (de) * 1999-10-12 2004-12-02 Daiichi Suntory Pharma Co., Ltd. Arzneimittel zur oralen verabreichung
US20040202714A1 (en) * 1999-10-12 2004-10-14 Daiichi Suntory Pharma Co., Ltd. Oral pharmaceutical composition
DE112005000488T5 (de) * 2004-03-04 2007-02-01 Gökhan, Cem Künstliche Früchte
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
US8722650B1 (en) 2005-06-24 2014-05-13 Medicis Pharmaceutical Corporation Extended-release minocycline dosage forms
US7544373B2 (en) * 2007-04-02 2009-06-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080241235A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080242642A1 (en) 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7541347B2 (en) * 2007-04-02 2009-06-02 Medicis Pharmaceutical Coropration Minocycline oral dosage forms for the treatment of acne
US20080241197A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline dosage forms for the treatment of acne
WO2010017310A1 (fr) 2008-08-06 2010-02-11 Medicis Pharmaceutical Corporation Procédé pour le traitement de l'acné, et certaines formes posologiques de celui-ci
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
US20230292801A1 (en) * 2022-03-18 2023-09-21 Kerry Group Services International Limited Crystalline sugar composite powder and methods for making the same

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2936307A (en) * 1957-12-16 1960-05-10 Bristol Myers Co Process of antibiotic extraction
US3079303A (en) * 1958-12-11 1963-02-26 Smith Kline French Lab Basic tablet granulation and process of using same
NL255376A (fr) * 1959-09-10
US3305447A (en) * 1963-06-12 1967-02-21 American Sugar Tabletting sugar and method of preparing same
US3351527A (en) * 1964-10-01 1967-11-07 American Home Prod Stabilized benzathine penicillin compositions
NL6607516A (fr) * 1966-05-31 1967-12-01
US3485914A (en) * 1966-07-05 1969-12-23 Chem & Pharm Patent Hold Ltd Process for the production of a pharmaceutical antibiotic preparation having delayed therapeutic action and the composition prepared according to such process
US3619292A (en) * 1968-07-15 1971-11-09 Penick & Ford Ltd Tablets and method of forming
US3639169A (en) * 1969-04-29 1972-02-01 Sucrest Corp Direct compression vehicles and method therefor
US3783159A (en) * 1970-08-07 1974-01-01 Pierrel Spa Pharmaceutical compositions containing kanamycin embonate
US3825528A (en) * 1970-08-20 1974-07-23 Bristol Myers Co Crystalline kanamycin tetrahydrochloride
US3781268A (en) * 1972-01-27 1973-12-25 Bristol Myers Co Antibiotic derivatives of kanamycin
US3855411A (en) * 1972-11-03 1974-12-17 American Home Prod Method of stabilization of 6-(1-aminocyclohexanecarboxamido) penicillanic acid and resultant compositions
US3802915A (en) * 1972-11-30 1974-04-09 Coco Cola Co Sugar coloring process

Also Published As

Publication number Publication date
FR2221179A1 (fr) 1974-10-11
DE2412117A1 (de) 1974-11-21
JPS49117612A (fr) 1974-11-11
GB1458431A (en) 1976-12-15
JPS5418330B2 (fr) 1979-07-06
US3932615A (en) 1976-01-13

Similar Documents

Publication Publication Date Title
AR201758A1 (fr)
AU465372B2 (fr)
AR201235Q (fr)
AR201231Q (fr)
AU474593B2 (fr)
FR2221179B1 (fr)
AU474838B2 (fr)
AU471343B2 (fr)
AU465453B2 (fr)
AU465434B2 (fr)
AU450229B2 (fr)
AR201229Q (fr)
AU466283B2 (fr)
AU472848B2 (fr)
AR199451A1 (fr)
AR201432A1 (fr)
AU461342B2 (fr)
AR210729A1 (fr)
AR200885A1 (fr)
AR195311A1 (fr)
AR195948A1 (fr)
AR200256A1 (fr)
AR197627A1 (fr)
AU447540B2 (fr)
AR196382A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse